1 in 9 persons tested found positive for infectious disease in ICMR study

New Delhi: Pathogens were found in 11.1 % of the 4.5 lakh patients tested by the network of labs under the Indian Council of Medical Research as part of efforts to identify viral infections of public health significance.

The top five pathogens detected were Influenza A in acute respiratory infection (ARI)/ severe acute respiratory infections (SARI cases), dengue virus among acute fever and haemorrhagic fever cases, Hepatitis A in jaundice cases, Norovirus in among acute diarrhoeal disease (ADD) outbreaks and Herpes simplex virus (HSV) in Acute Encephalitis Syndrome (AES) cases.

The spread of infectious diseases rose from 10.7 % in the first quarter to 11.5 % in the second quarter of 2025, according to the report by the Indian Council of Medical Research (ICMR). According to the Virus Research and Diagnostic Laboratories (VRDL) network of ICMR, between January and March, out of 2,28,856 samples, 24,502 (10.7 %) were found to contain pathogens from April to June 2025, 26,055 (11.5 %) out of 2,26,095 samples tested positive. Thus, the infection rate rose by 0.8 percentage points over the previous quarter, signalling the need for stronger monitoring of infection trends.

According to a senior scientist while this increase may not appear large, it should not be underestimated – it could serve as a warning for seasonal diseases and emerging infections.

If we continue tracking quarterly changes in infection rates, future epidemics could be prevented in time. The VRDL network acts as an early warning system for the country.

The ICMR report found that between April and June this year, 191 disease cluster were investigated and infectious diseases such as mumps, measles, rubella, dengue, chikungunya, rotavirus, norovirus, varicella zoster virus, Epstein-Barr virus (EBV) and astrovirus were identified.

Between January and March, 389 disease clusters were investigated and infectious diseases such as mumps, measles, rubella, hepatitis, dengue, chikungunya, rotavirus, influenza, Leptospira, Varicella zoster virus and Sexually transmitted infections (STIs) were identified.

From 2014-2024, more than 40 lakh samples were tested with pathogen identified in 18.8 %.

The VRDLN expanded from 27 laboratories in 2014 to 165 laboratories across 31 states and UTs by 2025. Through this network, 2,534 disease clusters have been identified across the country so far.

Related Posts

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

During the raid, the accused were allegedly found storing medicines and pharmaceutical drugs without valid licences, permits or authorisations and replacing labels on the stored medicines. The Directorate of Enforcement…

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Hyderabad startup PopVax develops personalised cancer vaccines using AI, machine learning, and mRNA tech to target unique tumour mutations. Cancer treatment is increasingly moving towards personalised approaches that take into…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Hyderabad Startup Working On Personalised Cancer Vaccine: What It Means For Cancer Treatment

Medicines that cure Us are making Our Environment Sick

Medicines that cure Us are making Our Environment Sick

ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

ZEN- G packs a punch in Organ Donation as Over 500 Students pledge Organs

PGIMS recalls drug amid probe into deaths

PGIMS recalls drug amid probe into deaths

NPPA list brings little relief: No price cut for 25% cancer drugs

NPPA list brings little relief: No price cut for 25% cancer drugs